Chairman, Dept. of Urology, University of Toledo Program Director
Urology
Dr. Steven H. Selman, MD
|
|
Give Review
Steven Selman works in the field of Urology. He studied medicine at Case Western Reserve University School of Medicine. He received awards:"Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Steven Selman is a published doctor. He published 99 publications, including: 'Iron-based second-sphere contrast agents for magnetic resonance imaging: development of a model system and evaluation of iron (III) tris (tironate) complex in rats.' Steven Selman accepts Medicare.
Publications
- Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat Bladder tumor model.
- Human 5-, 12- and 15-lipoxygenase-1 coexist in kidney but show opposite trends and their balance changes in Cancer.
- Editorial Comment on END-2011-0587-TE.R1.
- The McNeal Prostate: A Review.
- A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat Bladder tumor model.
- Beyond Buck's Fascia: The Life and Contributions of Dr. Gurdon Buck (1807-1877).
- Prostatic involution after intraprostatic injection of cobra toxin.
- Prevention and treatment of transitional cell carcinomatosis with intraperitoneal chemotherapy in a rat model.
- Replacement of intestinal mucosa with urothelium in rat augmented Bladders using intravesical photodynamic therapy with 5-aminolaevulinic acid.
- Intraperitoneal chemotherapy for the prevention of transitional cell carcinoma implantation.
- Vascular endothelial growth factor production in human prostate Cancer cells is stimulated by overexpression of platelet 12-lipoxygenase.
- Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells.
- Optical characteristics of the canine Prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy.
- Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at 2.1 A resolution.
- Inhibition of Bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.
- A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to Cancer and angiogenesis.
- Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence.
- Synthesis and in vivo photodynamic activity of some bacteriochlorin derivatives against Bladder tumors in rodents.
- Synthesis and in vivo activity of some porphyrindione derivatives with potential in photodynamic therapy.
- Metallopurpurins and light: effect on transplantable rat Bladder tumors and murine skin.
- Hemodynamic effect of the metallopurpurin SnET2 and light on transplantable FANFT induced Bladder tumor.
- Diels-Alder adducts of vinyl porphyrins: synthesis and in vivo photodynamic effect against a rat Bladder tumor.
- Cyclosporine versus azathioprine: a review of 200 consecutive cadaver Renal transplant recipients.
- Genitourinary malignancies.
- New sensitizers for photodynamic therapy: controlled synthesis of purpurins and their effect on normal tissue.
- Jejunal Blood flow after exposure to light in rats injected with hematoporphyrin derivative.
- Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat Bladder cells.
- Solid-phase purification and analysis of dicarboxylic porphyrins extracted from cultured tumor cells.
- Hematoporphyrin derivative photochemotherapy of experimental Bladder tumors.
- Morphologic studies of Bladder tumors treated with hematoporphyrin derivative photochemotherapy.
- Localization of hematoporphyrin derivative in injured Bladder mucosa. An experimental study.
- Small bilateral Renal cell carcinomas.
- New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable Bladder tumors.
- Morphological changes of tumor microvasculature following hematoporphyrin derivative sensitized photodynamic therapy.
- The use of the expanded polytetrafluoroethylene vascular graft as an adjunct to hypothermic pulsatile perfusion for Renal preservation.
- A dose response analysis of purpurin derivatives used as photosensitizers for the photodynamic treatment of transplantable FANFT induced urothelial tumors.
- Verdins: new photosensitizers for photodynamic therapy.
- Histological study of the effect of hematoporphyrin derivative photodynamic therapy on the rat jejunum.
- Photodynamic treatment of transplantable Bladder tumors in rodents after pretreatment with chloroaluminum tetrasulfophthalocyanine.
- Morphological study of the combined effect of purpurin derivatives and light on transplantable rat Bladder tumors.
- Anuria in transplant patient following inguinal herniorrhaphy.
- Correlation of tumor blood flow to tumor regression after hematoporphyrin derivative (HPD) photodynamic therapy to transplantable Bladder tumors.
- Blood flow in transplantable Bladder tumors treated with hematoporphyrin derivative and light.
- Chemical studies with hematoporphyrin derivative in Bladder cell lines.
- Percutaneous catheter drainage in treatment of urinary extravasation.
- A retrospective analysis of the use of ureteral stents in children undergoing ureteroneoCystotomy.
- Osteoblastic lesions in a patient with a Bladder filling defect.
- Arterial embolization of Renal allograft to control hemorrhage secondary to percutaneous nephropyelostomy.
- Appendico-ureterocutaneous fistula: report of a case.
- Systemic sporotrichosis: diagnosis through biopsy of epididymal mass.
- Ureteral injury: complication of partial excision of aortofemoral vascular prosthesis.
- Atheromatous changes in expanded polytetrafluoroethylene grafts.
- Tracer technique to measure in vivo chemical transport rates within an implantable cell transplantation device.
- Use of ileal urinary diversion in conJunction with intraoperative radiotherapy.
- Photodynamic therapy of tumors: effects of hematoporphyrin derivative on normal rat intestine.
- Exposure to alkyllysophospholipids inhibits in vitro invasion of transitional cell carcinoma.
- The effect of transurethral light on the canine Prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study.
- Photochemical ablation of intestinal mucosa for Bladder augmentation.
- Photodynamic therapy: a new modality for the treatment of Cancer.
- Computer simulation of Prostate cryoablation--fast and accurate approximation of the exact solution.
- Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the Prostate.
- Sexual activity, contraception, and reproductive factors in predicting endometriosis.
- Pneumococcal conjugate vaccine for young children.
- Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus Infection.
- Improvement of in-rumen digestibility of alfalfa forage by genetic manipulation of lignin O-methyltransferases.
- Menstrual cycle characteristics and the risk of endometriosis.
- Iron-based second-sphere contrast agents for magnetic resonance imaging: development of a model system and evaluation of iron (III) tris (tironate) complex in rats.
- VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
- Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
- Accelerated thrombus lysis in the Blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-life.
- Very long half-life plasminogen activator inhibitor type 1 reduces bleeding in a mouse model.
- Laparoscopic management of extensive ureteral fibroepithelial polyps.
- Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total Blood loss.
- Nutraceutical inhibitors of urokinase: potential applications in prostate Cancer prevention and treatment.
- PAI-1 induces cell detachment, downregulates nucleophosmin (B23) and fortilin (TCTP) in LnCAP prostate Cancer cells.
- Diverse optical characteristic of the Prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy.
- Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.
- Transperineal in vivo fluence-rate dosimetry in the canine Prostate during SnET2-mediated PDT.
- Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
- In vivo and in vitro effect of baicalein on human prostate Cancer cells.
- Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine Prostate: implications for computer simulation of photodynamic therapy.
- Structure of curcumin in complex with lipoxygenase and its significance in Cancer.
- Copper benzochlorin, a novel photosensitizer for photodynamic therapy: effects on a transplantable urothelial tumor.
- Transperineal photodynamic ablation of the canine Prostate.
- Aspirin blocks binding of photosensitizer SnET2 into human serum albumin: implications for photodynamic therapy.
- Iminium salt benzochlorins: structure-activity relationship studies.
- Massive necrotizing pancreatitis in an immunosuppressed Renal transplant recipient (successful therapy).
- Enhanced skin allograft survival after photodynamic therapy. Association with lymphocyte inactivation and macrophage stimulation.
- Cyclosporine versus azathioprine: a 5-year followup of 200 consecutive cadaver Renal transplant recipients.
- Iminium salt of copper benzochlorin (CDS1), a novel photosensitizer for photodynamic therapy: mechanism of cell killing.
- Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate Cancer xenografts in SCID mice.
- Studies of tin ethyl etiopurpurin photodynamic therapy of the canine Prostate.
- Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.
- Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate Cancer.
- Successful treatment of a Renal arteriovenous fistula with a Fogarty catheter.
- Mechanisms of cell killing in photodynamic therapy using a novel in vivo drug/in vitro light culture system.
- Observations on the synthesis and in vivo photodynamic activity of some benzochlorins.
- A new technique for Bladder washing.
Schools
Case Western Reserve University School of Medicine
University Hosps
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystometry
- View All
Conditions Treated
- Atrophic Vaginitis
- Balanoposthitis
- Bladder Atony
- Bladder Cancer
- View All
Doctors Specialties
- General Surgery
- Urology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Case Western Reserve University - University Hospitals -
Case Western Reserve University School of Medicine
Hospital
-
Mercy St. Vincent Medical Center
Drug Facts
| NPI NUMBER | 1073509089 | |
| NPPES Provider LastName | SELMAN | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 436142595 | |
| NPPES Provider State | OH | |
| Specialty Description | Urology | |
| Total Claim Count | 599.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073509089 |
| Last Name Of The Provider | SELMAN |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. Peter F. Klein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manuel L. De La Serna, MD |
|
|
Dr. Lloyd A. Jacobs, MD |
|
|
Dr. Joseph Roshe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. A A. Mancini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mayer L. Wainstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory D. Haselhuhn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hosea Payne, MD |
|
|
Dr. Evan M. Fynes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dino Santacroce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan D. Wright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khaled Shahrour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick M. Irwin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine J. Ou, DO |
|
|
Heitham S. Albeshri, MB BS |
|
|
Jai Prasad, MB BS
This Doctor is OpenDoctor Recommended.
|